Jury rules against plaintiffs in Actos trial - 8 News NOW

Jury rules against plaintiffs in Actos trial

Posted: Updated:
Attorney Robert Eglet was seeking a multi-billion dollar verdict. Attorney Robert Eglet was seeking a multi-billion dollar verdict.
LAS VEGAS -- The jury has ruled against two southern Nevada women in the product liability trial involving a controversial diabetes drug.

Delores Cipriano and Bertha Triana sued the Tokyo-based pharmaceutical company Takeda over the diabetes drug Actos. They claimed the drug gave them bladder cancer and that the company did not warn users of the drugs' dangers.

Both women are diabetic and were prescribed the drug by their doctors to help them control their blood sugar. Both women developed bladder cancer. The U.S. Food and Drug Administration warned in June 2011 that the drug may increase the risk of bladder cancer

However, Takeda Pharmaceutical pointed out that 70,000 people develop bladder cancer each year. In statement, the company said it agreed with the verdict and reiterated the drugs' benefits,

"Takeda is confident in the therapeutic benefits of ACTOS and its importance as a treatment for type 2 diabetes and we will continue to defend the company vigorously in these cases,"  senior vice president and general counsel Kenneth D. Greisman said.

The company also said the verdict is its fifth win out six cases brought against it and the drug. It is challenging the ruling in the sixth case. In that case, a jury ordered the company to pay $9 billion in damages to a person who had developed bladder cancer while taking the drug.

The women were asking for a multi-billion dollar verdict, the largest in Nevada history.
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KLAS. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.